SCOTT BLORE: Open Payments
NPI 1063405710 · PLUMSTEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 25 payments from 12 companies in 2025. Trend: 2023 $933 · 2024 $629 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Lilly USA, LLC | 3 | $63 |
| Astellas Pharma US Inc | 2 | $57 |
| PFIZER INC. | 3 | $53 |
| ABBVIE INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $38 |
| Amgen Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: MOUNJARO, Veozah, JARDIANCE, PREVNAR 20, FARXIGA, INJECTAFER, TEFLARO, LEQVIO.
Industry payments across PA — which companies pay providers there.
